In this episode, the Oncology Brothers speak with world-renowned thoracic oncologist Dr. Jarushka Naidoo of Royal College of Surgeons in Ireland to learn about her approach for treating metastatic non-small cell lung cancer (NSCLC) with actionable mutations in the first line setting. This algorithm is important in the space of thoracic oncology, because as stated by Dr. Naidoo, NSCLC is “the poster child for precision medicine.”